Current Report Filing (8-k)
June 14 2021 - 04:55PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 Or 15(d) of the Securities Exchange Act
of 1934
Date of Report (Date of earliest event reported): June 8, 2021
GB Sciences, Inc.
(Exact name of Registrant as specified in its charter)
Nevada
(State or other Jurisdiction of
Incorporation or organization)
|
000-55462
(Commission File Number)
|
59-3733133
(IRS Employer I.D. No.)
|
3550 W. Teco Avenue
Las Vegas, NV 89118
(Address of Principal Executive Offices) (Zip Code)
(844) 843-2569
Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
☐
Soliciting
material pursuant to Rule l 4a- l 2 under the Exchange Act ( 17 CFR
240. l 4a- l 2)
☐
Pre-commencement
communications pursuant to Rule l 4d-2(b) under the Exchange Act
(17 CFR 240. l 4d-2(b))
☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240. l 3e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
None
|
N/A
|
N/A
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 5.02 Appointment of Certain Officers.
Effective June 8, 2021, the board of directors (the “Board”) of the
registrant (the “Company”) elected Zach Swarts to serve as the
treasurer of the Company. Mr. Swarts is currently serving as the
chief financial officer of the Company. His resume is on page 84 of
the Company’s Form 10-K filed with the SEC on August 28, 2020.
Also effective June 8, 2021, the Board confirmed the appointment of
Gary R. Henrie as the secretary of the Company. Mr. Henrie is an
attorney licensed to practice law in the State of Utah since 1987
and in the State of Nevada since 2003. Mr. Henrie was appointed an
officer of the United State Supreme Court by the United States
Supreme Court in June, 2014. Mr. Henrie has served as legal counsel
to public companies for the past 32 years and has been securities
counsel for the Company since 2014.
SIGNATURE PAGE
Pursuant to the requirement of the Securities and Exchange Act of
1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
GB
Sciences, Inc.
a
Nevada corporation
|
|
|
|
|
|
|
Dated: June 14, 2021
|
|
By:
|
/s/ John Poss
|
|
|
|
|
John Poss
|
|
|
|
|
Chief Financial Officer
|
|
GB Sciences (QB) (USOTC:GBLX)
Historical Stock Chart
From May 2022 to Jun 2022
GB Sciences (QB) (USOTC:GBLX)
Historical Stock Chart
From Jun 2021 to Jun 2022